Practical Aspects of Continuous Intravenous Treprostinil Therapy

Allison C. Widlitz, MS, PA-C, Susanne McDevitt, RN, MSN, ACNP,Ginger R. Ward, RN and Abby Krichman, RRT

Learning Objectives - At the completion of this program, the learner will be able to:

Objective 1:	Describe the pathophysiology of pulmonary arterial hypertension (PAH)
Objective 2:	Identify appropriate clinical assessment parameters for evaluating patients with PAH
Objective 3:	Discuss effective nursing management of patients receiving continuous intravenous treprostinil therapy

Program Title and Description

Practical Aspects of Continuous Intravenous Treprostinil Therapy

Publication/Sponsor Information

Critical Care Nurse is an official publication of the American Association of Critical-Care Nurses (AACN), and copyright belongs to AACN. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording or by any information storage retrieval system without permission of AACN. For all permission requests, please contact the Copyright Clearance Center, Customer Service, 222 Rosewood Drive, Danvers, MA 01923. (978) 750-8400. The statements and opinions contained herein are solely those of individual contributors and not of the editors, AACN, or The InnoVision Group. The editors, AACN, and The InnoVision Group assume that articles emanating from a particular institution are submitted with the approval of the requisite authority, including all matters pertaining to human studies and patient privacy requirements.

Click on the title below to view
Practical Aspects of Continuous Intravenous Treprostinil Therapy

In order to read some of the CE content you will need to download the following FREE reader:

Take Test